Correcting RAG1 Deficiency Using CRISPR/CAS9

被引:0
|
作者
de Bruin, L. Ott [1 ]
Lee, Y. N. [1 ]
Musunuru, K. [2 ]
Notarangelo, L. D. [1 ]
机构
[1] Boston Childrens Hosp, Boston, MA USA
[2] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ESID-0632
引用
收藏
页码:S183 / S183
页数:1
相关论文
共 50 条
  • [41] Structure and mechanism of CRISPR/Cas9
    Taylor, David W.
    JOURNAL OF ANIMAL SCIENCE, 2019, 97 : 56 - 57
  • [42] Anything impossible with CRISPR/Cas9?
    Renjie Jiao
    Caixia Gao
    Science China Life Sciences, 2017, 60 : 445 - 446
  • [43] Putting the brakes on CRISPR–Cas9
    Vesna Todorovic
    Nature Methods, 2017, 14 : 108 - 108
  • [44] CRISPR/Cas9: Prospects and Challenges
    Zhang, Feng
    HUMAN GENE THERAPY, 2015, 26 (07) : 409 - 410
  • [45] Allergan dives into CRISPR–Cas9
    Nature Biotechnology, 2017, 35 : 296 - 296
  • [46] CRISPR screens beyond Cas9
    Burgess, Darren J.
    NATURE REVIEWS GENETICS, 2020, 21 (05) : 273 - 273
  • [47] CRISPR/Cas9 in Gastrointestinal Malignancies
    Jefremow, Andre
    Neurath, Markus F.
    Waldner, Maximilian J.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [48] The Potential of CRISPR/Cas9 in Hematotherapy
    Bak, Rasmus O.
    STEM CELLS AND DEVELOPMENT, 2019, 28 (11) : 710 - 711
  • [49] Bets Placed On CRISPR/Cas9
    Thayer, Ann
    CHEMICAL & ENGINEERING NEWS, 2015, 93 (48) : 16 - 16
  • [50] Genome modification by CRISPR/Cas9
    Ma, Yuanwu
    Zhang, Lianfeng
    Huang, Xingxu
    FEBS JOURNAL, 2014, 281 (23) : 5186 - 5193